Company / Operating Income per Share
DNA X, Inc. Operating Income per Share History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
$0.12
FY2024
5-year range
-$4.41 / $0.12
FY2020-FY2024
Trend
+133.1%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income per Share has increased for 3 consecutive years, from $-4.41 in FY2021 to $0.12 in FY2024.
Based on SEC 10-K filings.
0.12 in FY2024 with a 5-year CAGR of -19.6%.
Improved from $-2.02 to $0.12 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -19.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- DNA X, Inc.'s operating income per share has grown for 3 consecutive years.
- In FY2024, operating income per share increased 133.1% year-over-year.
- Peak operating income per share was recorded in FY2019.
- Lowest operating income per share in the period was in FY2021.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.12 | +133.1% |
| FY2023 | -$0.35 | +82.7% |
| FY2022 | -$2.02 | +54.2% |
| FY2021 | -$4.41 | -302.9% |
| FY2020 | -$1.10 | -416.5% |
| FY2019 | $0.35 | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026